InvestorsHub Logo
Followers 7
Posts 1057
Boards Moderated 0
Alias Born 05/12/2016

Re: AlexSwiss post# 154012

Saturday, 12/01/2018 7:12:30 PM

Saturday, December 01, 2018 7:12:30 PM

Post# of 203912
Alex, the letter from M. Bignitz said the last study participant had started the 6 week clinical 3 weeks ago. Just a gentle reminder that after this next 3 weeks, the findings will need to be tabulated, added to the findings from other approved clinical participants, then a summary drawn on this second part of the safety trials. I would think the managements goal is to have these results ready to be publicly released prior to the J.P. Morgan conference, which is slated for mid-January 2019 (not mid-December). JMHO

The track record for releasing info, to date, has not been what most on this board would consider as expedious but...we have management that are not "pumping" research/administrative results but only releasing pertinent info/results they feel as necessary and without compromising a growing IP arsenal that other biopharm's would love to find loopholes within.

Sandy